Skip to main content
. 2013 Apr;25(2):155–160. doi: 10.3978/j.issn.1000-9604.2013.03.07

Table 2. Incidence of hematologic toxicities related to BTD regimen in each group (%).

Group 1
Group 2
Grade 1-2 Grade 3-4 Grade 1-2 Grade 3-4
Thrombocytopenia 16 (38.1%) 4 (9.5%) 12 (40.0%) 4 (13.3%)
Anemia 10 (23.8%) 5 (11.9%) 10 (30.0%) 4 (13.3%)
Neutropenia 8 (19.0%) 2 (4.8%) 4 (13.3%) 1 (3.3%)